SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Mark S. Sulkowski, Hugo E. Vargas, Adrian M. Di Bisceglie, Alexander Kuo, K. Rajender Reddy, Joseph K. Lim, Giuseppe Morelli, Jama M. Darling, Jordan J. Feld, Robert S. Brown, Lynn M. Frazier, Thomas G. Stewart, Michael W. Fried, David R. Nelson, Ira M. Jacobson, Effectiveness of Simeprevir Plus Sofosbuvir, With or Without Ribavirin, in Real-World Patients With HCV Genotype 1 Infection, Gastroenterology, 2016, 150, 2, 419

    CrossRef

  2. 2
    Ming V. Lin, Lindsay Y. King, Raymond T. Chung, Hepatitis C Virus–Associated Cancer, Annual Review of Pathology: Mechanisms of Disease, 2015, 10, 1, 345

    CrossRef

  3. 3
    Wei Teng, Tzu-Ching Chang, Chien-Hao Huang, Wen-Juei Jeng, Wei-Ting Chen, Chang-Wen Huang, Yu-Pin Ho, Chun-Yen Lin, I-Shyan Sheen, IL28B polymorphism and early anemia predict the rapid null response in genotype-1 chronic hepatitis C with dual therapy, Advances in Digestive Medicine, 2015, 2, 4, 128

    CrossRef

  4. 4
    Bashar A. Aqel, Surakit Pungpapong, Michael Leise, K. Tuesday Werner, Amy E. Chervenak, Kymberly D. Watt, Jennifer L. Murphy, Kristen Ryland, Andrew P. Keaveny, Ryan McLemore, Hugo E. Vargas, Multicenter experience using simeprevir and sofosbuvir with or without ribavirin to treat hepatitis C genotype 1 in patients with cirrhosis, Hepatology, 2015, 62, 4
  5. 5
    Amandeep Singh, Nayere Zaeri, Immanuel K. Ho, Onset of Celiac Disease after Treatment of Chronic Hepatitis C with Interferon Based Triple Therapy, Case Reports in Hepatology, 2015, 2015, 1

    CrossRef

  6. 6
    Takuro Igawa, Soichiro Fushimi, Ryuichi Matsuo, Fusao Ikeda, Kazuhiro Nouso, Tadashi Yoshino, Harushige Nakatsukasa, Severe liver injury associated with simeprevir plus pegylated interferon/ribavirin therapy in a patient with treatment-naïve genotype 1b hepatitis C virus: a case report, Clinical Journal of Gastroenterology, 2014, 7, 5, 465

    CrossRef